» Articles » PMID: 23808384

Lysophosphatidic Acid Receptor-2 Deficiency Confers Protection Against Bleomycin-induced Lung Injury and Fibrosis in Mice

Overview
Date 2013 Jul 2
PMID 23808384
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic pulmonary fibrosis is a devastating disease characterized by alveolar epithelial cell injury, the accumulation of fibroblasts/myofibroblasts, and the deposition of extracellular matrix proteins. Lysophosphatidic acid (LPA) signaling through its G protein-coupled receptors is critical for its various biological functions. Recently, LPA and LPA receptor 1 were implicated in lung fibrogenesis. However, the role of other LPA receptors in fibrosis remains unclear. Here, we use a bleomycin-induced pulmonary fibrosis model to investigate the roles of LPA2 in pulmonary fibrogenesis. In the present study, we found that LPA2 knockout (Lpar2(-/-)) mice were protected against bleomycin-induced lung injury, fibrosis, and mortality, compared with wild-type control mice. Furthermore, LPA2 deficiency attenuated the bleomycin-induced expression of fibronectin (FN), α-smooth muscle actin (α-SMA), and collagen in lung tissue, as well as levels of IL-6, transforming growth factor-β (TGF-β), and total protein in bronchoalveolar lavage fluid. In human lung fibroblasts, the knockdown of LPA2 attenuated the LPA-induced expression of TGF-β1 and the differentiation of lung fibroblasts to myofibroblasts, resulting in the decreased expression of FN, α-SMA, and collagen, as well as decreased activation of extracellular regulated kinase 1/2, Akt, Smad3, and p38 mitogen-activated protein kinase. Moreover, the knockdown of LPA2 with small interfering RNA also mitigated the TGF-β1-induced differentiation of lung fibroblasts. In addition, LPA2 deficiency significantly attenuated the bleomycin-induced apoptosis of alveolar and bronchial epithelial cells in the mouse lung. Together, our data indicate that the knockdown of LPA2 attenuated bleomycin-induced lung injury and pulmonary fibrosis, and this may be related to an inhibition of the LPA-induced expression of TGF-β and the activation and differentiation of fibroblasts.

Citing Articles

Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF).

Aribindi K, Liu G, Albertson T Expert Rev Clin Pharmacol. 2024; 17(9):817-835.

PMID: 39192604 PMC: 11441789. DOI: 10.1080/17512433.2024.2396121.


Lysophosphatidic acid receptor 1 inhibition: a potential treatment target for pulmonary fibrosis.

Volkmann E, Denton C, Kolb M, Wijsenbeek-Lourens M, Emson C, Hudson K Eur Respir Rev. 2024; 33(172).

PMID: 39009409 PMC: 11262619. DOI: 10.1183/16000617.0015-2024.


The Role of Lysophospholipid Metabolites LPC and LPA in the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Zhou Q, Chen Y, Liang Y, Sun Y Metabolites. 2024; 14(6).

PMID: 38921452 PMC: 11205356. DOI: 10.3390/metabo14060317.


Functional meniscus reconstruction with biological and biomechanical heterogeneities through topological self-induction of stem cells.

Du M, Liu K, Lai H, Qian J, Ai L, Zhang J Bioact Mater. 2024; 36:358-375.

PMID: 38496031 PMC: 10944202. DOI: 10.1016/j.bioactmat.2024.03.005.


Autotaxin inhibition attenuates the aortic valve calcification by suppressing inflammation-driven fibro-calcific remodeling of valvular interstitial cells.

Yoon D, Choi B, Kim J, Kim E, Chung S, Min H BMC Med. 2024; 22(1):122.

PMID: 38486246 PMC: 10941471. DOI: 10.1186/s12916-024-03342-x.


References
1.
Watterson K, Lanning D, Diegelmann R, Spiegel S . Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen. 2007; 15(5):607-16. DOI: 10.1111/j.1524-475X.2007.00292.x. View

2.
Pradere J, Gonzalez J, Klein J, Valet P, Gres S, Salant D . Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta. 2008; 1781(9):582-7. PMC: 2577601. DOI: 10.1016/j.bbalip.2008.04.001. View

3.
Raghu G, Freudenberger T, Yang S, Curtis J, Spada C, Hayes J . High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006; 27(1):136-42. DOI: 10.1183/09031936.06.00037005. View

4.
Pradere J, Klein J, Gres S, Guigne C, Neau E, Valet P . LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol. 2007; 18(12):3110-8. DOI: 10.1681/ASN.2007020196. View

5.
Lepparanta O, Sens C, Salmenkivi K, Kinnula V, Keski-Oja J, Myllarniemi M . Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung. Cell Tissue Res. 2012; 348(3):491-503. DOI: 10.1007/s00441-012-1385-9. View